Yevstigneev S V, Titarenko A F, Abakumova T R, Alexandrova E G, Khaziakhmetova V N, Ziganshina L E
Int J Risk Saf Med. 2015;27 Suppl 1:S59-60. doi: 10.3233/JRS-150690.
Rational use of medicines remains to be one of the most challenging problems in health systems worldwide [1, 2]. ABC/VEN-analysis has been recommended for use by the World Health Organization (WHO) and has been used in health care practice globally since 1981. It represents the simple and effective method of analysis of medicine expenditures, identifying priority groups of medicines, the use of which, when improved, may provide the greatest clinical and economic impact. ABC analysis provides an accurate and objective picture of budget expenditures on medicines. VEN-analysis helps to prioritize between various medicines in their selection for procurement and use within a drug supply system [3-5].
To assess the impact of introduction of evidence-based principles in the practice of medicine procurement and use on budget expenditures on medicines of a multidisciplinary health facility for the period of four years (2011-2014).
ABC/VEN analysis was carried out in a multidisciplinary health facility with over 1000 beds (an average number of beds for three years), which is responsible for provision of care to the population of about 1.4 million people. The analysis was carried out on the basis of information on medicine expenditures for 4 years: 2011 (1st year), 2012 (2nd year), 2013 (3rd year) and 2014 (4th year). When assigning VEN categories of medicines we used expert method: assignment of categories was carried out by clinical pharmacologists after reviewing all available evidence on effectiveness, safety and cost-effectiveness compared to other drugs in this group. In 2013, we implemented educational intervention, including detailed discussion of the results of the ABC/VEN-analysis for the years 2011-2012 from the standpoint of evidence-based pharmacology and recommendations for medicine procurement. In 2014, we delivered training workshop for the heads of clinical departments on evidence-based principles in clinical pharmacology and rational use of medicines.
Medicines expenditures of the studied health facility for the year 2014 were less than for the year 2013, which was the important decrease reversing the trend of increasing medicines expenditures of the last three years: 2011 - 59,868,963 roubles; 2012 - 85,324,084 roubles, 2013 - 107 303 390 roubles, and 2014 - 74,416,692 roubles. The number of International Non-proprietary Names (INN) of medicines used in 2014 was 519, which was the highest number for the four years of the study: 2011 - 429 INN, 2012 - 432 INN, 2013 - 513 INN, and 2014 - 519 INN. Nearly 40% of the funds spent in 2014 on medicines have been used for Vital medicines: 2011 - 26%, 2012 - 39%, 2013 - 25%. Expenditures on Non-essential medicines in 2014 were about the same as in previous years - 14% of total medicine expenditures: 2011 - 16%, 2012 - 13%, 2013 - 15%. However in absolute numbers (roubles) expenditures on non-essential medicines decreased compared to the years 2013 and 2012: 2011 - 9,428,135 roubles, 2012 - 11,129,388 roubles, 2013 - 15,578,325 roubles, 2014 - 10,616,023 roubles.Expenditures on solutions for infusion (sodium chloride, Ringer's solution, dextran, glucose, hydroxyethyl starch) decreased as compared to the year 2013, but still remained high, thus indicating on the abuse of parenteral methods of drug administration. The portion of expenditures on isotonic sodium chloride solution and hydroxyethyl starch in 2014 decreased compared to the year 2013. We found a positive trend in the structure of expenditures on antibacterial agents: in 2014 expenditures on fluoroquinolones decreased nearly fivefold compared to 2013, expenditures on cephalosporins also decreased, but not so dramatically. However, there was a significant increase in expenditures on carbapenems, more than twofold compared with the year 2013. In 2014 we noted a twofold decrease in expenditures on medicines affecting blood, including antithrombotic agents, hemostatics and antianemic medicines, as compared to the values of the year 2013. In 2014 there was also a decrease in expenditures of cardio-vascular medicines, medicines affecting nervous system, alimentary tract and metabolism.
Introduction of evidence-based principles through educational interventions at a multidisciplinary health facility resulted in a number of changes towards more rational medicine use. Regular educational interventions for practicing physicians and heads of clinical departments of health facilities that promote rational prescribing are needed.
合理用药仍然是全球卫生系统中最具挑战性的问题之一[1,2]。ABC/VEN分析已被世界卫生组织(WHO)推荐使用,自1981年以来已在全球医疗实践中应用。它是一种简单有效的药物支出分析方法,可确定药物的优先类别,改进这些药物的使用可能会产生最大的临床和经济影响。ABC分析能准确客观地反映药物预算支出情况。VEN分析有助于在药品供应系统内选择采购和使用的各种药物之间确定优先顺序[3-5]。
评估在四年(2011 - 2014年)期间,将循证原则引入多学科医疗机构的药品采购和使用实践对药品预算支出的影响。
在一家拥有超过1000张床位(三年平均床位数)、负责为约140万人口提供医疗服务的多学科医疗机构中进行ABC/VEN分析。分析基于2011年(第1年)、2012年(第2年)、2013年(第3年)和2014年(第4年)这4年的药品支出信息。在确定药品的VEN类别时,我们采用专家方法:由临床药理学家在审查了与该组其他药物相比的所有有效性、安全性和成本效益的现有证据后进行类别分配。2013年,我们实施了教育干预,包括从循证药理学角度详细讨论2011 - 2012年ABC/VEN分析的结果以及药品采购建议。2014年,我们为临床科室负责人举办了关于临床药理学循证原则和合理用药的培训研讨会。
该研究医疗机构2014年的药品支出低于2013年,这是一个重要的下降,扭转了过去三年药品支出增加的趋势:2011年 - 59868963卢布;2012年 - 85324084卢布,2013年 - 107303390卢布,2014年 - 74416692卢布。2014年使用的药品国际非专利名称(INN)数量为519种,这是研究四年中的最高数量:2011年 - 429种INN,2012年 - 432种INN,2013年 - 513种INN,2014年 - 519种INN。2014年用于基本药物的资金近40%:2011年 - 26%,2012年 - 39%,2013年 - 25%。2014年非必需药物的支出与前几年大致相同 - 占药品总支出14%:2011年 - 16%,2012年 - 13%,2013年 - 15%。然而,按绝对数字(卢布)计算,非必需药物的支出与2013年和2012年相比有所下降:2011年 - 9428135卢布,2012年 - 11129388卢布,2013年 - 15578325卢布,2014年 - 10616023卢布。与2013年相比,输液溶液(氯化钠、林格氏液、右旋糖酐、葡萄糖、羟乙基淀粉)的支出有所下降,但仍然很高,这表明存在滥用肠外给药方法的情况。2014年等渗氯化钠溶液和羟乙基淀粉的支出比例与2013年相比有所下降。我们发现抗菌药物支出结构呈现积极趋势:2014年氟喹诺酮类药物的支出与2013年相比下降了近五倍,头孢菌素类药物的支出也有所下降,但幅度没有那么大。然而,碳青霉烯类药物的支出显著增加,与2013年相比增加了两倍多。2014年,我们注意到影响血液的药物支出与2013年相比下降了两倍,包括抗血栓药物、止血药物和抗贫血药物。2014年心血管药物、影响神经系统、消化道和代谢的药物支出也有所下降。
通过在多学科医疗机构进行教育干预引入循证原则,带来了一些朝着更合理用药方向的变化。需要对执业医师和医疗机构临床科室负责人进行定期教育干预,以促进合理处方。